Deccan Healthcar

Deccan_Healthcar03 May 2024

Healthcare

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Deccan Healthcar

Deccan Healthcar

Healthcare

Deccan_Healthcar03 May 2024

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-Jan-2024	BC	DECCAN HEALTH CARE LIMITED has informed BSE about Board Meeting to be held on 02 Jun 2024 to consider financial statements for the period ended December 2024. Financial results / Other business.	02-Jun-2024
11-Mar-2024	BC	With reference to our Intimation vide letter dated Wednesday, March 06, 2024 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, March 11, 2024 have I	12-Apr-2024
06-Mar-2024	BC	Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/03/2024 inter alia to consider and approve 1. Appointment(s)/Recruitment(s) of Addi	11-Mar-2024
11-Mar-2024	BC	With reference to our Intimation vide letter dated Wednesday, March 06, 2024 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, March 11, 2024 have I	11-Mar-2024
29-Jan-2024	BC	Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve 1. To consider and approve Unaudited Fin	06-Feb-2024

No Rights has been declared by Deccan_Healthcar

Book Closure

Record Date	Split Date	Purpose
02-Jun-2024	-	DECCAN HEALTH CARE LIMITED has informed BSE about Board Meeting to be held on 02 Jun 2024 to consider financial statements for the period ended December 2024. Financial results / Other business.
12-Apr-2024	01 Jan'1900	With reference to our Intimation vide letter dated Wednesday, March 06, 2024 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, March 11, 2024 have I
11-Mar-2024	-	Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/03/2024 inter alia to consider and approve 1. Appointment(s)/Recruitment(s) of Addi
11-Mar-2024	-	With reference to our Intimation vide letter dated Wednesday, March 06, 2024 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, March 11, 2024 have I
06-Feb-2024	-	Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve 1. To consider and approve Unaudited Fin

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Deccan Health Care Ltd ₹26.10(0.00/0.00%)	26.10	+0.00	53.18	-11.82	31.07	0.57
Kovai Medical Center & Hospital Ltd ₹4,070.00(+9.30/0.23%)	4,070.00	+9.30	4,442.41	105.40	28.10	5.69
Shree Pacetronix Ltd ₹228.80(-2.05/-0.89%)	228.80	-2.05	83.09	89.22	21.24	7.33
Fortis Malar Hospitals Ltd ₹87.41(-1.78/-2.00%)	87.41	-1.78	167.16	79.96	0.00	2.93
Chennai Meenakshi Multispeciality Hospital Ltd ₹35.51(0.00/0.00%)	35.51	+0.00	26.53	70.48	98.64	148.77
Apollo Hospitals Enterprise Ltd ₹6,014.60(+58.60/0.98%)	6,014.60	+58.60	85,638.14	32.88	85.76	11.74

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	15.34	17.19	11.22	15.86	8.65	11.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	15.34	17.19	11.22	15.86	8.65	11.77
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.01	0.01	0.01	0.00
Total Income	15.34	17.19	11.23	15.86	8.66	11.77
Total Expenditure	14.11	16.17	10.40	15.06	8.83	10.97
PBIDT	1.24	1.03	0.83	0.80	-0.18	0.80
Interest	0.02	0.00	0.02	0.03	0.04	0.03
PBDT	1.22	1.03	0.81	0.77	-0.21	0.78
Depreciation	0.40	0.32	0.39	0.36	0.36	0.36
Tax	0.32	0.20	0.15	0.13	-0.10	0.11
Deferred Tax	-0.05	-0.02	-0.04	-0.02	-0.04	-0.01
Reported Profit After Tax	0.55	0.53	0.31	0.31	-0.43	0.32
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.55	0.53	0.31	0.31	-0.43	0.32

EPS (Unit Curr.)	0.31	0.31	0.18	0.19	-0.25	0.18
EPS (Adj) (Unit Curr.)	0.31	0.31	0.18	0.19	-0.25	0.18
Calculated EPS (Unit Curr.)	0.27	0.31	0.18	0.18	-0.25	0.19
Calculated EPS (Adj) (Unit Curr.)	0.27	0.31	0.18	0.18	-0.25	0.19
Calculated EPS (Ann.) (Unit Curr.)	1.08	1.24	0.74	0.73	-1.00	0.75
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.08	1.24	0.74	0.73	-1.00	0.75
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	20.38	17.04	17.04	17.04	17.04	17.04
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	8.08	5.99	7.40	5.04	-2.08	6.80
PBDTM(%)	7.95	5.99	7.22	4.85	-2.43	6.63
PATM(%)	3.59	3.08	2.76	1.95	-4.97	2.72

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	15.34	17.19	11.24	15.86	8.65	11.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	15.34	17.19	11.24	15.86	8.65	11.77
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.01	0.01	0.01	0.00
Total Income	15.34	17.20	11.24	15.86	8.66	11.77
Total Expenditure	14.12	16.15	10.43	15.13	8.85	10.99
PBIDT	1.22	1.04	0.81	0.74	-0.20	0.78
Interest	0.04	0.00	0.02	0.03	0.04	0.03
PBDT	1.19	1.04	0.79	0.71	-0.23	0.76
Depreciation	0.40	0.32	0.39	0.36	0.36	0.36
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.31	0.20	0.14	0.11	-0.09	0.11
Deferred Tax	-0.05	-0.02	-0.04	-0.02	-0.04	-0.01
Reported Profit After Tax	0.53	0.54	0.30	0.27	-0.46	0.30
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	0.53	0.54	0.30	0.27	-0.46	0.30

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.53	0.54	0.30	0.27	-0.46	0.30

EPS (Unit Curr.)	0.29	0.32	0.18	0.16	-0.27	0.17
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	20.38	17.04	17.04	17.04	17.04	17.04

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	7.95	6.05	7.21	4.67	-2.31	6.63
PBDTM(%)	7.76	6.05	7.03	4.48	-2.66	6.46
PATM(%)	3.46	3.14	2.67	1.70	-5.32	2.55

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	17.04	15.71	15.71	15.71	15.71	13.50
Reserves Total	64.61	61.23	60.91	60.52	50.43	32.68
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	81.65	76.94	76.62	76.23	66.14	46.18
Secured Loans	0.49	1.12	0.82	1.07	1.18	10.62
Unsecured Loans	0.13	0.13	0.21	0.23	0.23	0.28
Total Debt	0.62	1.25	1.03	1.30	1.41	10.90
Total Liabilities	82.27	78.19	77.65	77.53	67.55	57.08
APPLICATION OF FUNDS :
Gross Block	33.24	33.49	33.60	33.51	31.70	27.27
Less : Accumulated Depreciation	16.39	14.96	13.73	12.26	10.85	9.56
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	16.85	18.53	19.87	21.25	20.85	17.71
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.07	0.00	0.00	3.51
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	46.75	46.50	44.98	37.90	32.09	19.61
Sundry Debtors	12.05	12.82	12.47	20.56	19.38	17.67
Cash and Bank	1.39	2.66	3.21	3.45	4.48	0.31
Loans and Advances	15.34	5.96	5.79	3.95	1.14	1.33
Total Current Assets	75.53	67.95	66.45	65.86	57.09	38.93
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	11.37	9.66	10.40	11.34	11.41	9.19
Provisions	0.77	0.53	1.94	1.83	1.63	2.02
Total Current Liabilities	12.15	10.19	12.34	13.17	13.04	11.21
Net Current Assets	63.39	57.76	54.10	52.69	44.04	27.72
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	2.03	2.10	2.13	2.14	2.09	2.01
Net Deferred Tax	-2.03	-2.10	-2.13	-2.14	-2.09	-2.01
Total Assets	78.22	74.20	71.92	71.80	62.80	46.93
Contingent Liabilities	17.02	15.71	15.65	10.51	0.50	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	2.66	3.21	3.45	4.48	0.31
Net Cash from Operating Activities	-5.85	-0.57	0.22	2.68	2.62
Net Cash Used In Investing Activities	0.25	-0.05	-0.08	-1.94	-11.53
Net Cash Used In Financing Activities	4.33	0.07	-0.37	-1.77	13.07
Net Inc./Dec In Cash And Cash Equivalents	-1.27	-0.55	-0.23	-1.03	4.16
Cash And Cash Equivalents At End Of The Year	1.39	2.66	3.21	3.45	4.48

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

16.12%

FII Shareholding

0.00%

DII Shareholding

6.53%

Public Shareholding

77.35%

**Promoter pledged shareholding 16.12%

About Deccan Health Care Ltd

Deccan Health Care Ltd is in the Healthcare sector, having a market capitalization of Rs. 53.18 crores. It has reported a sales of Rs. 15.34 crores and a net profit of Rs. 0.55 crores for the quarter ended December 2018. The company management includes Minto Gupta, Minto Gupta,Meenakshi Gupta,Ruchi Khattar,Kandlakunta Samhitha,Ravi Ram Prasad,Viraj Shaileshkumar Shah (Deccan Health Care Ltd) among others.

Chairman

Minto Gupta

Registered office

247 2nd Flr Dwarakapuri Colony,Punjagutta,Hyderabad,Telangana,500082

FAX :

Background

Incorporation Year1996

Face Value₹10

Market Lot1

How to buy Deccan Healthcar shares on nse?

To buy Deccan Healthcar shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Deccan Healthcar share price today?

The Deccan Healthcar shares price on nse is Rs.26.1 today.

What is the market cap of Deccan Healthcar shares on BSE ?

The company has a market capitalization of Rs.53.18Cr

What is the PE & PB ratio of Deccan Healthcar shares ?

PE is 31.07 and PB is 0.57

What is the 52 Week High and Low of Deccan Healthcar shares?

Deccan Healthcar stock price high: Rs.42 Deccan Healthcar stock price low: Rs.23.1